Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries.
<h4>Background</h4>Xpert MTB/XDR (Xpert-XDR) testing can significantly shorten time to initiating appropriate drug-resistant tuberculosis (DR-TB) treatment, but its introduction may impact laboratory workflow, especially in laboratories not currently performing drug susceptibility testin...
Saved in:
| Main Authors: | Sara Keller, Kogieleum Naidoo, Medhane Zekarias, Sussan Israel-Isah, Mohammed Shaka, Gcinile Gule, Anushka Naidoo, Miriam Bathnna, Judith Nomthandazo Dlamini-Miti, Kalkidan Yae, Evaezi Okpokoro, Alash'le Abimiku, Ahmed Bedru, Edine W Tiemersma, TRiAD Study Consortium |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0326342 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Feasibility and acceptability of GeneXpert MTB/XDR implementation among healthcare workers in three low-middle income African countries
by: Sara Keller, et al.
Published: (2025-01-01) -
Triage test for all-oral drug-resistant tuberculosis (DR-TB) regimen: a phase IV study to assess effectiveness, feasibility, acceptability and cost-effectiveness of the Xpert MTB/XDR assay for rapid triage and treatment of DR-TB
by: Kogieleum Naidoo, et al.
Published: (2024-11-01) -
Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
by: Florence O Bada, et al.
Published: (2020-01-01) -
Aetiology, Clinical Presentation, and Outcome of Meningitis in Patients Coinfected with Human Immunodeficiency Virus and Tuberculosis
by: Smita Bhagwan, et al.
Published: (2011-01-01) -
HIV-Associated Tuberculosis
by: Kogieleum Naidoo, et al.
Published: (2011-01-01)